FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913871097> ?p ?o ?g. }

• W2913871097 abstract "Abstract Pharmaceutical agents currently approved for the treatment of multiple sclerosis reduce relapse rates, but do not reverse or prevent neurodegeneration nor initiate myelin repair. The highly selective estrogen receptor (ER) β ligand chloroindazole (IndCl) shows particular promise promoting both remyelination while reducing inflammatory cytokines in the central nervous system of mice with experimental autoimmune encephalomyelitis. To optimize these benefits, we developed and screened seven novel IndCl analogues for their efficacy in promoting primary oligodendrocyte (OL) progenitor cell survival, proliferation, and differentiation in vitro by immunohistochemistry. Two analogues, IndCl- o -chloro and IndCl- o -methyl, induced proliferation and differentiation equivalent to IndCl and were selected for subsequent in vivo evaluation for their impact on clinical disease course, white matter pathology, and inflammation. Both compounds ameliorated disease severity, increased mature OLs, and improved overall myelination in the corpus callosum and white matter tracts of the spinal cord. These effects were accompanied by reduced production of the OL toxic molecules interferon-γ and chemokine (C-X-C motif) ligand, CXCL10 by splenocytes with no discernable effect on central nervous system-infiltrating leukocyte numbers, while IndCl- o -methyl also reduced peripheral interleukin (IL)−17. In addition, expression of the chemokine CXCL1, which is associated with developmental oligodendrogenesis, was upregulated by IndCl and both analogues. Furthermore, callosal compound action potential recordings from analogue-treated mice demonstrated a larger N1 component amplitude compared to vehicle, suggesting more functionally myelinated fibers. Thus, the o -Methyl and o -Chloro IndCl analogues represent a class of ERβ ligands that offer significant remyelination and neuroprotection as well as modulation of the immune system; hence, they appear appropriate to consider further for therapeutic development in multiple sclerosis and other demyelinating diseases." @default.
• W2913871097 created "2019-02-21" @default.
• W2913871097 creator A5012523502 @default.
• W2913871097 creator A5026203045 @default.
• W2913871097 creator A5050058027 @default.
• W2913871097 creator A5054090841 @default.
• W2913871097 creator A5054214062 @default.
• W2913871097 creator A5058893742 @default.
• W2913871097 creator A5061099441 @default.
• W2913871097 creator A5069167592 @default.
• W2913871097 creator A5078480946 @default.
• W2913871097 creator A5084110637 @default.
• W2913871097 date "2019-01-24" @default.
• W2913871097 modified "2023-09-24" @default.
• W2913871097 title "Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis" @default.
• W2913871097 cites W112338602 @default.
• W2913871097 cites W1501784975 @default.
• W2913871097 cites W1763258797 @default.
• W2913871097 cites W1765057352 @default.
• W2913871097 cites W1892477107 @default.
• W2913871097 cites W1914553247 @default.
• W2913871097 cites W1969708254 @default.
• W2913871097 cites W1971355501 @default.
• W2913871097 cites W1973144368 @default.
• W2913871097 cites W1992699495 @default.
• W2913871097 cites W1996369704 @default.
• W2913871097 cites W1998987960 @default.
• W2913871097 cites W2000599573 @default.
• W2913871097 cites W2001593633 @default.
• W2913871097 cites W2003807965 @default.
• W2913871097 cites W2010232340 @default.
• W2913871097 cites W2015915974 @default.
• W2913871097 cites W2019476809 @default.
• W2913871097 cites W2021898378 @default.
• W2913871097 cites W2022101759 @default.
• W2913871097 cites W2023125910 @default.
• W2913871097 cites W2026218766 @default.
• W2913871097 cites W2026951449 @default.
• W2913871097 cites W2033788318 @default.
• W2913871097 cites W2034329390 @default.
• W2913871097 cites W2034767058 @default.
• W2913871097 cites W2034964129 @default.
• W2913871097 cites W2038933398 @default.
• W2913871097 cites W2039686256 @default.
• W2913871097 cites W2045072541 @default.
• W2913871097 cites W2048684002 @default.
• W2913871097 cites W2050597784 @default.
• W2913871097 cites W2050732746 @default.
• W2913871097 cites W2057544171 @default.
• W2913871097 cites W2061068109 @default.
• W2913871097 cites W2071768705 @default.
• W2913871097 cites W2078448182 @default.
• W2913871097 cites W2079944307 @default.
• W2913871097 cites W2085818023 @default.
• W2913871097 cites W2108435061 @default.
• W2913871097 cites W2109168755 @default.
• W2913871097 cites W2112383150 @default.
• W2913871097 cites W2137782572 @default.
• W2913871097 cites W2139485237 @default.
• W2913871097 cites W2146919072 @default.
• W2913871097 cites W2150107812 @default.
• W2913871097 cites W2151826099 @default.
• W2913871097 cites W2152982261 @default.
• W2913871097 cites W2155432054 @default.
• W2913871097 cites W2158064024 @default.
• W2913871097 cites W2164401185 @default.
• W2913871097 cites W2165578318 @default.
• W2913871097 cites W2256155471 @default.
• W2913871097 cites W2605033539 @default.
• W2913871097 cites W2624289631 @default.
• W2913871097 cites W2806436973 @default.
• W2913871097 cites W3144832212 @default.
• W2913871097 cites W4300542283 @default.
• W2913871097 cites W48085598 @default.
• W2913871097 doi "https://doi.org/10.1038/s41598-018-37420-x" @default.
• W2913871097 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6345788" @default.
• W2913871097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30679747" @default.
• W2913871097 hasPublicationYear "2019" @default.
• W2913871097 type Work @default.
• W2913871097 sameAs 2913871097 @default.
• W2913871097 citedByCount "17" @default.
• W2913871097 countsByYear W29138710972019 @default.
• W2913871097 countsByYear W29138710972020 @default.
• W2913871097 countsByYear W29138710972021 @default.
• W2913871097 countsByYear W29138710972022 @default.
• W2913871097 countsByYear W29138710972023 @default.
• W2913871097 crossrefType "journal-article" @default.
• W2913871097 hasAuthorship W2913871097A5012523502 @default.
• W2913871097 hasAuthorship W2913871097A5026203045 @default.
• W2913871097 hasAuthorship W2913871097A5050058027 @default.
• W2913871097 hasAuthorship W2913871097A5054090841 @default.
• W2913871097 hasAuthorship W2913871097A5054214062 @default.
• W2913871097 hasAuthorship W2913871097A5058893742 @default.
• W2913871097 hasAuthorship W2913871097A5061099441 @default.
• W2913871097 hasAuthorship W2913871097A5069167592 @default.
• W2913871097 hasAuthorship W2913871097A5078480946 @default.
• W2913871097 hasAuthorship W2913871097A5084110637 @default.
• W2913871097 hasBestOaLocation W29138710971 @default.
• W2913871097 hasConcept C126322002 @default.
• W2913871097 hasConcept C169760540 @default.

• next